|
|||||
|
|
| X线立体定向放射治疗44例腹膜后转移癌近期疗效观察 | |
| 引用本文： | 席青松,于世英,胡广原. X线立体定向放射治疗44例腹膜后转移癌近期疗效观察[J]. 中德临床肿瘤学杂志, 2006, 5(5): 347-349. DOI: 10.1007/s10330-005-0451-0 |
| 作者姓名： | 席青松 于世英 胡广原 |
| 作者单位： | Cancer Center of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
| 摘 要： | Objective： To investigate the therapeutic effects of stereotactic radiotherapy for retroperitoneal metastatic tumor. Methods： From August 1997 to October 2004, 44 patients with retroperitoneal metastatic tumors were treated with stereotactic radiotherapy. The planning target volume was encompassed by 90%-95% isodose line. Fractional dose was from 6 Gy to 8 Gy, and they were treated 2-3 times per-week and 4-8 times in all. The total radiation doses of PTV were from 32 Gy to 48 Gy. Results： After the radiotherapy, the pain was obviously relieved in 81.8% patients. Three months after completion of radiotherapy passed and then, abdominal CT was performed to evaluate the results. The whole effective rate was 81.8% [CR 27.7% （12/44） and PR 54.5% （24/44）], and six months after radiotherapy, CR was 27.7% （12/44） and PR was 59.1% （26/44）. The middle survival time was 12 months. Conclusion： It is suggested that stereotactic radiotherapy for retroperitoneal metastatic tumor is a safe and effective method. |
| 关 键 词： | 治疗效果 放射治疗 腹膜后肿瘤 病理 |
| 收稿时间： | 2005-10-14 |
| 修稿时间： | 2006-09-07 |
Observation of the therapeutic efficacy of stereotactic radiotherapy in 44 cases of retroperitoneal metastatic tumor |
|
| Qingsong Xi,Shiying Yu,Guangyuan Hu. Observation of the therapeutic efficacy of stereotactic radiotherapy in 44 cases of retroperitoneal metastatic tumor[J]. The Chinese-German Journal of Clinical Oncology, 2006, 5(5): 347-349. DOI: 10.1007/s10330-005-0451-0 | |
| Authors: | Qingsong Xi Shiying Yu Guangyuan Hu |
| Affiliation: | (1) Cancer Center of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China |
| Abstract: | Objective: To investigate the therapeutic effects of stereotactic radiotherapy for retroperitoneal metastatic tumor. Methods: From August 1997 to October 2004, 44 patients with retroperitoneal metastatic tumors were treated with stereotactic radiotherapy. The planning target volume was encompassed by 90%–95% isodose line. Fractional dose was from 6 Gy to 8 Gy, and they were treated 2–3 times per-week and 4–8 times in all. The total radiation doses of PTV were from 32 Gy to 48 Gy. Results: After the radiotherapy, the pain was obviously relieved in 81.8% patients. Three months after completion of radiotherapy passed and then, abdominal CT was performed to evaluate the results. The whole effective rate was 81.8% [CR 27.7% (12/44) and PR 54.5% (24/44)], and six months after radiotherapy, CR was 27.7% (12/44) and PR was 59.1% (26/44). The middle survival time was 12 months. Conclusion: It is suggested that stereotactic radiotherapy for retroperitoneal metastatic tumor is a safe and effective method. |
| Keywords: | retroperitoneal metastatic tumor stereotactic radiotherapy fractionated stereotactic radiotherapy |
| 本文献已被 CNKI 维普 万方数据 SpringerLink 等数据库收录！ | |